Mankind Pharma schedules investor call on May 20, 2026 to discuss Q4FY26 and full-year FY26 business performance and results.
Senior management including VC & MD Rajeev Juneja and CEO Sheetal Arora will represent the company during the call.
Disclosure made pursuant to SEBI Listing Regulations 30 and 51 regarding scheduled corporate communication event.
Conference call will be conducted via Zoom platform from 12:00 PM to 1:00 PM IST for investor participation.